Comparison of tear proteins between healthy and early diabetic retinopathy patients

Clinical Biochemistry

Volumn 45, Issue 1-2, 2012, Pages 60-67

  Kim, Hyun Jung ^a   Kim, Pan Kyeom ^a   Yoo, Hyun Syuk ^a   Kim, Chan Wha ^a  

^a Korea University   (South Korea)

Author keywords

Diabetic retinopathy; Nonproliferative diabetic retinopathy; Proliferative diabetic retinopathy; Tear protein; Two dimensional gel electrophoresis

Indexed keywords

ADENINE PHOSPHORIBOSYLTRANSFERASE; BETA 2 MICROGLOBULIN; BETA GLOBIN; BIOLOGICAL MARKER; CALGRANULIN; CALGRANULIN A; CALGRANULIN B; CALVASCULIN; CYTOKERATIN 4; DJ 1 PROTEIN; ENVELOPE PROTEIN; HEAT SHOCK PROTEIN 27; KERATIN 31; LIPOCALIN 1; LIPOCALIN 1 PRECURSOR PROTEIN; LYSOZYME; PHOSPHOHISTIDINE PHOSPHATASE; SAP1 PROTEIN; TEAR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS;

ADULT; BIOLOGICAL MARKERS; DIABETIC RETINOPATHY; DISEASE PROGRESSION; EYE PROTEINS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PROGNOSIS; PROTEOMICS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 84855302577     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.10.006     Document Type: Article

References (45)

1. Bjerrum K.B. Primary Sjogren's syndrome and keratoconjunctivitis sicca: diagnostic methods, frequency and social disease aspects. Acta Ophthalmol Scand Suppl 2000, 1-37.
2. Janssen P.T., Vanbijsterveld O.P. The relations between tear fluid concentrations of lysozyme, tear-specific pre-albumin and lactoferrin. Exp Eye Res 1983, 36:773-779.
3. Vanhaeringen N.J. Clinical biochemistry of tears. Surv Ophthalmol 1981, 26:84-96.
4. Rapacz P., Tedesco J., Donshik P.C., Ballow M. Tear lysozyme and lactoferrin levels in giant papillary conjunctivitis and vernal conjunctivitis. CLAO J 1988, 14:207-209.
5. Fullard R.J., Snyder C. Protein levels in nonstimulated and stimulated tears of normal human subjects. Invest Ophthalmol Vis Sci 1990, 31:1119-1126.
6. Glasson M.J., Molloy M.P., Walsh B.J., Willcox M.D., Morris C.A., Williams K.L. Development of mini-gel technology in two-dimensional electrophoresis for mass-screening of samples: application to tears. Electrophoresis 1998, 19:852-855.
7. Molloy M.P., Bolis S., Herbert B.R., Ou K., Tyler M.I., van Dyk D.D., et al. Establishment of the human reflex tear two-dimensional polyacrylamide gel electrophoresis reference map: new proteins of potential diagnostic value. Electrophoresis 1997, 18:2811-2815.
8. Kim C.W., Koo B.S., Lee D.Y., Ha H.S., Kim J.C. Comparative analysis of the tear protein expression in blepharitis patients using two-dimensional electrophoresis. J Proteome Res 2005, 4:719-724.
9. Ananthi S., Santhosh R.S., Nila M.V., Prajna N.V., Lalitha P., Dharmalingam K. Comparative proteomics of human male and female tears by two-dimensional electrophoresis. Exp Eye Res 2011, 92:454-463.
10. Saijyothi A.V., Angayarkanni N., Syama C., Utpal T., Shweta A., Bhaskar S., et al. Two dimensional electrophoretic analysis of human tears: collection method in dry eye syndrome. Electrophoresis 2010, 31:3420-3427.
11. Versura P., Nanni P., Bavelloni A., Blalock W.L., Piazzi M., Roda A., et al. Tear proteomics in evaporative dry eye disease. Eye 2010, 24:1396-1402.
12. Lema I., Brea D., Rodriguez-Gonzalez R., Diez-Feijoo E., Sobrino T. Proteomic analysis of the tear film in patients with keratoconus. Mol Vis 2010, 16:2055-2061.
13. Feener E.P., Gao B.B., Chen X.H., Timothy N., Aiello L.P. Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy. J Proteome Res 2008, 7:2516-2525.
14. Kempen J.H., O'Colmam B.J., Leske C., Haffner S.M., Klein R., Moss S.E., et al. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol-Chic 2004, 122:552-563.
15. Aiello L.P., Gardner T.W., King G.L., Blankenship G., Cavallerano J.D., Ferris F.L., et al. Diabetic retinopathy. Diabetes Care 1998, 21:143-156.
16. Moss S.E., Klein R., Klein B.E. The incidence of vision loss in a diabetic population. Ophthalmology 1988, 95:1340-1348.
17. Ahn B.Y., Song E.S., Cho Y.J., Kwon O.W., Kim J.K., Lee N.G. Identification of an anti-aldolase autoantibody as a diagnostic marker for diabetic retinopathy by immunoproteomic analysis. Proteomics 2006, 6:1200-1209.
18. Fong D.S., Aiello L., Gardner T.W., King G.L., Blankenship G., Cavallerano J.D., et al. Retinopathy in diabetes. Diabetes Care 2004, 27(Suppl. 1):S84-S87.
19. Jones D.T., Monroy D., Pflugfelder S.C. A novel method of tear collection: comparison of glass capillary micropipettes with porous polyester rods. Cornea 1997, 16:450-458.
20. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
21. Kim H.J., Cho E.H., Yoo J.H., Kim P.K., Shin J.S., Kim M.R., et al. Proteome analysis of serum from type 2 diabetics with nephropathy. J Proteome Res 2007, 6:735-743.
22. Kim H.J., Yoo H.S., Kim P.K., Kim M.R., Lee H.W., Kim C.W. Comparative analysis of serum proteomes of patients with cardiovascular disease. Clin Biochem 2011, 44:178-184.
23. Ito C., Maeda R., Ishida S., Harada H., Inoue N., Sasaki H. Importance of OGTT for diagnosing diabetes mellitus based on prevalence and incidence of retinopathy. Diabetes Res Clin Pract 2000, 49:181-186.
24. Stratton I.M., Kohner E.M., Aldington S.J., Turner R.C., Holman R.R., Manley S.E., et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6years from diagnosis. Diabetologia 2001, 44:156-163.
25. Boehm B.O., Lang G., Volpert O., Jehle P.M., Kurkhaus A., Rosinger S., et al. Low content of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor predicts progression of diabetic retinopathy. Diabetologia 2003, 46:394-400.
26. Leto G., Pricci F., Amadio L., Iacobini C., Cordone S., Diaz-Horta O., et al. Increased retinal endothelial cell monolayer permeability induced by the diabetic milieu: role of advanced non-enzymatic glycation and polyol pathway activation. Diabetes Metab Res Rev 2001, 17:448-458.
27. Xu S.Y., Venge P. Lipocalins as biochemical markers of disease. BBA-Protein Struct Mol Enzymol 2000, 1482:298-307.
28. Fullard R.J., Kissner D.M. Purification of the isoforms of tear specific prealbumin. Curr Eye Res 1991, 10:613-628.
29. Glasgow B.J., Abduragimov A.R., Farahbakhsh Z.T., Faull K.F., Hubbell W.L. Tear lipocalins bind a broad array of lipid ligands. Curr Eye Res 1995, 14:363-372.
30. Abduragimov A.R., Gasymov O.K., Yusifov T.N., Glasgow B.J. Functional cavity dimensions of tear lipocalin. Curr Eye Res 2000, 21:824-832.
31. Glasgow B.J., Marshall G., Gasymov O.K., Abduragimov A.R., Yusifov T.N., Knobler C.M. Tear lipocalins: potential lipid scavengers for the corneal surface. Invest Ophthalmol Vis Sci 1999, 40:3100-3107.
32. Yamada M., Mochizuki H., Kawai M., Tsubota K., Bryce T.J. Decreased tear lipocalin concentration in patients with meibomian gland dysfunction. Br J Ophthalmol 2005, 89:803-805.
33. Janssen P.T., Vanbijsterveld O.P. Tear fluid proteins in Sjogrens-syndrome. Scand J Rheumatol 1986, 224-227.
34. Glasgow B.J. Tissue expression of lipocalins in human lacrimal and von Ebner's glands: colocalization with lysozyme. Graefes Arch Clin Exp Ophthalmol 1995, 233:513-522.
35. Selsted M.E., Martinez R.J. Isolation and purification of bactericides from human tears. Exp Eye Res 1982, 34:305-318.
36. Chen H., Wu X.J., Lu X.Y., Zhu L., Wang L.P., Yang H.T., et al. Phosphorylated heat shock protein 27 is involved in enhanced heart tolerance to ischemia in short-term type 1 diabetic rats. Acta Pharmacol Sin 2005, 26:806-812.
37. Henderson B., Shamaei-Tousi A., Stephens J.W., Bin R., Cooper J.A., Steptoe A., et al. Association between plasma levels of heat shock protein 60 and cardiovascular disease in patients with diabetes mellitus. Eur Heart J 2006, 27:1565-1570.
38. Esposito G., Michelutti R., Verdone G., Viglino P., Hernandez H., Robinson C.V., et al. Removal of the N-terminal hexapeptide from human beta2-microglobulin facilitates protein aggregation and fibril formation. Protein Sci 2000, 9:831-845.
39. Cooke J.P., Wilson A.M., Kimura E., Harada R.K., Nair N., Narasimhan B., et al. Beta 2-microglobulin as a biomarker in peripheral arterial disease - proteomic profiling and clinical studies. Circulation 2007, 116:1396-1403.
40. Berggard I., Bearn A.G. Isolation and properties of a low molecular weight beta-2-globulin occurring in human biological fluids. J Biol Chem 1968, 243:4095-4103.
41. Oakley B.R., Kirsch D.R., Morris N.R. A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels. Anal Biochem 1980, 105:361-363.
42. Hochstrasser D.F., Patchornik A., Merril C.R. Development of polyacrylamide gels that improve the separation of proteins and their detection by silver staining. Anal Biochem 1988, 173:412-423.
43. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
44. Chung L.W.K., Nomura T., Huang W.C., Seo S., Zhau H.E., Mimata H. Targeting beta 2-microglobulin mediated signaling as a novel therapeutic approach for human renal cell carcinoma. J Urol 2007, 178:292-300.
45. Al-Taee I.K., Al-Safar J.J., Al-Falahi Y.S., Al-Shamma I.A. The clinical significance of beta2-microglobulin in end-stage renal disease. Saudi J Kidney Dis Transpl 2003, 14:492-496.